(19)
(11) EP 4 225 362 A2

(12)

(88) Date of publication A3:
19.05.2022

(43) Date of publication:
16.08.2023 Bulletin 2023/33

(21) Application number: 21802021.2

(22) Date of filing: 08.10.2021
(51) International Patent Classification (IPC): 
A61K 39/12(2006.01)
C07K 14/00(2006.01)
 A61P 31/14(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 39/12; C12N 2770/20034; A61K 2039/58; A61K 2039/70; A61P 31/14
(86) International application number:
PCT/IT2021/050325
(87) International publication number:
WO 2022/074698 (14.04.2022 Gazette 2022/15)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 09.10.2020 IT 202000023809

(71) Applicants:
  • Craniomed Group S.r.l.
    83038 Montemiletto (AV) (IT)
  • Petrillo, Mauro
    21014 Laveno-Monbello (VA) (IT)
  • Petrillo, Fabio
    80038 Pomigliano d'Arco (NA) (IT)
  • Bisaccia, Domenico Rocco
    84098 Pontecagnano Faiano (SA) (IT)
  • Marsan Consulting S.r.l.
    80128 Napoli (NA) (IT)

(72) Inventor:
  • BROGNA, Carlo
    83038 MONTEMILETTO (AV) (IT)

(74) Representative: Gitto, Serena et al
Barzanò & Zanardo Roma S.p.A. Via Piemonte, 26
00187 Roma
00187 Roma (IT)

   


(54) ANATOXINS AND ANTIBODIES FOR USE IN THE PREVENTION AND TREATMENT OF CORONAVIRUS DISEASE